DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, announced the extension of its marketing and distribution agreement with Cincinnati-based Ethicon Endo-Surgery, Inc.
